Assignee
RIPPLE THERAPEUTICS CORP
CA·9 granted patents·12 pending applications·16 citations·filing 2019–2024
Top patents by PatentIndex Score
21 records- 0193US10588862B2Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 17, 2020·5 cites·50 claims
- 0292US10959954B2Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 30, 2021·3 cites·19 claims
- 0392US10945958B2Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 16, 2021·3 cites·19 claims
- 0492US10632075B2Glass formulations and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Apr 28, 2020·4 cites·29 claims
- 0585US2025049719A1Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 0684US11279729B2Heterodimer compositions and methods for the treatment of ocular disordersRIPPLE THERAPEUTICS CORP·Filed 2021·Granted Mar 22, 2022·1 cites·11 claims
- 0781US2023225975A1Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 0875US11612567B2Ocular inserts comprising a covalently linked steroid dimerRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 28, 2023·0 cites·15 claims
- 0975US2025065053A1Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 1072US2021205222A1Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 1168US2023113525A1Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 1263US2025074935A1Heterodimer compositions and methods for the treatment of ocular disordersRIPPLE THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 1363US2026007686A1Compositions and methods for improving visionRIPPLE THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 1461US11464914B2Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2020·Granted Oct 11, 2022·0 cites·20 claims
- 1561US2022387213A1Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 1661US2025057962A1Processable compositions and use for the sameRIPPLE THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 1760US2022106351A1Heterodimer compositions and methods for the treatment of ocular disordersRIPPLE THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 1855US12473326B2Crystalline forms of dexamethasone dimers and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2020·Granted Nov 18, 2025·0 cites·12 claims
- 1950US12509469B2Compositions and methods for the treatment of pain and dependence disordersRIPPLE THERAPEUTICS CORP·Filed 2020·Granted Dec 30, 2025·0 cites·13 claims
- 2049US2022289787A1Dimer combinations and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 2148US2022288277A1Surface coatings and implantable devices comprising dimeric steroid prodrugs, and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →